Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: Impact on the early morning period

American Journal of Hypertension

Volumn 17, Issue 4, 2004, Pages 347-353

  White, William B ^a   Lacourciere, Yves ^b   Davidai, Giora ^c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Ambulatory blood pressure; Angiotensin receptor blockers; Early morning period; Telmisartan

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; PLACEBO; TELMISARTAN; VALSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG HALF LIFE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CANADA; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; SYSTOLE; TETRAZOLES; TREATMENT OUTCOME; UNITED STATES; VALINE;

EID: 1842562367     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.02.016     Document Type: Article

References (21)

1. White W.B. Ambulatory blood pressure monitoring in clinical practice. N Engl J Med. 348:2003;2377-2378.
2. Mansoor G.A., White W.B. Ambulatory blood pressure and cardiovascular risk. J Vasc Med Biol. 5:1994;61-68.
3. White W.B. Methods of blood pressure determination to assess antihypertensive therapy. Are casual measurements enough? Clin Pharmacol Ther. 45:1989;581-586.
4. Muller J.E., Tofler G.H., Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 79:1989;733-743.
5. Marler J.R., Price T.R., Clark G.L., Muller J.E., Robertson T., Mohr J.P., Hier D.B., Wolf P.A., Caplan L., Foulkes M.A. Morning increase in the onset of ischemic stroke. Stroke. 20:1989;473-476.
6. White W.B. Circadian variation of blood pressure clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit. 2:1997;47-52.
7. Kario K., Pickering T.G., Umeda Y., Hoshide S., Hoshide Y., Morinari M., Murata M., Kuroda T., Schwatz J.E., Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives a prospective study. Circulation. 107:2003;1401-1406.
8. Anwar Y.A., White W.B. Chronotherapeutics for cardiovascular disease. Drugs. 55:1998;631-643.
9. McClennan K.J., Markham A. Telmisartan. Drugs. 56:1998;1039-1044.
10. Lacourciere Y., Lenis J., Orchard R., Lewanczuk R., Houde M., Pesant Y., Wright J., Wilson T., Martin K. A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit. 3:1998;295-302.
11. Flesch G., Muller P., Lloyd P. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist in man. Eur J Clin Pharmacol. 52:1997;115-120.
12. Markham A., Goa K.L. Valsartan a review of its pharmacology and therapeutic use in essential hypertension. Drugs. 54:1997;299-311.
13. White W.B. Advances in ambulatory blood pressure monitoring for the evaluation of antihypertensive therapy in research and practice. White W.B. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. 2001;273-298 Humana Press, Totowa, NJ.
14. White W.B., Black H.R., Weber M.A., Elliott W.J., Bryzinski B., Fakouhi T.D. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart-rate blood pressure product. Am J Cardiol. 81:1998;424-431.
15. Medical Dictionary for Regulatory Activities Terminology (MedDRA): Version 3.3, Reston, VA, MedDRA MSSO, December 2000
16. Dodt C., Breckling U., Derad I., Fehm H.L., Born J. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension. 30:1997;71-76.
17. Tofler G.H., Bezinkski D., Schafer A.I., Czeisler C.A., Rutherford J., Willich S.N., Gleason R.E., Williams G.H., Muller J.E. Concurrent morning increases in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 316:1987;1514-1518.
18. Kawano Y., Tochikubo O., Minamisawa K., Miyahima E., Ishii M. Circadian variation of hemodynamics in patients with essential hypertension comparison between early morning and evening. J Hypertens. 12:1994;1405-1412.
19. Littlejohn T., Mroczek W., Marbury T., VanderMaelen C.P., Dubiel R.F. A prospective, randomized open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol. 16:2000;1123-1132.
20. Mallion J.M., Siche J.P., Lacourciere Y. Ambulatory BP monitoring comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens. 13:1999;657-664.
21. Lacourciere Y., Asmar R. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients. Am J Hypertens. 12:1999;1181-1187.